R Schleyerbach

500 total citations
14 papers, 398 citations indexed

About

R Schleyerbach is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, R Schleyerbach has authored 14 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in R Schleyerbach's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). R Schleyerbach is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). R Schleyerbach collaborates with scholars based in Germany, Canada and Japan. R Schleyerbach's co-authors include R. R. Bartlett, G. H. Thoenes, H. U. Schorlemmer, Claudius Küchle, Alison Finnegan, M Dimitrijevic, Eric G. Bremer, Tieno Germann, Karl Langer and Erwin Rüde and has published in prestigious journals such as Diabetologia, Osteoarthritis and Cartilage and Inflammation Research.

In The Last Decade

R Schleyerbach

14 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R Schleyerbach Germany	9	142	81	68	57	55	14	398
Szu-Yu Kuo Taiwan	10	228 1.6×	94 1.2×	80 1.2×	54 0.9×	48 0.9×	15	497
Kazuhiko Yukioka Japan	13	142 1.0×	59 0.7×	34 0.5×	50 0.9×	27 0.5×	18	334
D. Welsch United States	9	174 1.2×	75 0.9×	30 0.4×	32 0.6×	44 0.8×	11	475
Katsuyoshi Kawana Japan	8	139 1.0×	124 1.5×	61 0.9×	125 2.2×	92 1.7×	11	519
Weiguo Xiao China	14	120 0.8×	146 1.8×	142 2.1×	75 1.3×	26 0.5×	33	468
Robert H. Keith United States	12	135 1.0×	41 0.5×	150 2.2×	57 1.0×	36 0.7×	19	409
Michael Rosenbach United States	9	374 2.6×	159 2.0×	80 1.2×	132 2.3×	50 0.9×	9	671
C. Brindley United Kingdom	11	322 2.3×	49 0.6×	150 2.2×	79 1.4×	18 0.3×	14	523
Michele L. Kus United Kingdom	8	219 1.5×	183 2.3×	177 2.6×	82 1.4×	75 1.4×	9	571
William A. Skoog United States	8	211 1.5×	42 0.5×	97 1.4×	57 1.0×	32 0.6×	13	560

Countries citing papers authored by R Schleyerbach

Since Specialization

Citations

This map shows the geographic impact of R Schleyerbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Schleyerbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Schleyerbach more than expected).

Fields of papers citing papers by R Schleyerbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Schleyerbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Schleyerbach. The network helps show where R Schleyerbach may publish in the future.

Co-authorship network of co-authors of R Schleyerbach

This figure shows the co-authorship network connecting the top 25 collaborators of R Schleyerbach. A scholar is included among the top collaborators of R Schleyerbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Schleyerbach. R Schleyerbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Dimitrova, Petya, et al.. (2001). Leflunomide Inhibits Proliferation of Th 1 Effectors and Biases for Th 2 Cell Differentiation. 41(2). 359. 1 indexed citations

Weithmann, K. U., et al.. (1997). Effects of tiaprofenic acid on urinary pyridinium crosslinks in adjuvant arthritic rats: Comparison with doxycycline. Inflammation Research. 46(7). 246–252. 5 indexed citations

Margerie, Daniel, Johannes Flechtenmacher, Frank Büttner, et al.. (1997). Complexity of IL-1β induced gene expression pattern in human articular chondrocytes. Osteoarthritis and Cartilage. 5(2). 129–138. 28 indexed citations

Raiss, R., A. Karbowski, Thomas Aigner, & R Schleyerbach. (1995). Chondrocytes and antirheumatic drugs.. PubMed. 43. 152–4. 6 indexed citations

Bartlett, R. R., et al.. (1993). Effects of leflunomide on immune responses and models of inflammation. Springer Seminars in Immunopathology. 14(4). 70 indexed citations

Bartlett, R. R., M Dimitrijevic, Tieno Germann, et al.. (1991). Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Inflammation Research. 32(1-2). 10–21. 155 indexed citations

Küchle, Claudius, G. H. Thoenes, Karl Langer, et al.. (1991). Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent.. PubMed. 23(1 Pt 2). 1083–6. 37 indexed citations

Schorlemmer, H. U., et al.. (1991). Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis.. PubMed. 17(10-11). 471–84. 3 indexed citations

Bartlett, R. R., et al.. (1990). Pharmacological profile of HWA-131, a novel antiinflammatory agent with immunomodulating properties. Inflammation Research. 29(1-2). 71–73. 10 indexed citations

10.

Thoenes, G. H., Thomas Sitter, Karl Langer, R. R. Bartlett, & R Schleyerbach. (1989). Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats. International Journal of Immunopharmacology. 11(8). 921–929. 32 indexed citations

11.

Alpermann, H. G., et al.. (1986). Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat.. PubMed. 36(11). 1605–8. 22 indexed citations

12.

Schleyerbach, R, et al.. (1984). Alterations in the gastro-intestinal functions during the development of adjuvant disease in rats. Inflammation Research. 15(3-4). 392–397. 17 indexed citations

13.

Bickel, Marcel H., K. Geisen, & R Schleyerbach. (1978). Studies on the effect of tolbutamide, glibenclamide, HB 699, and glucose on serum insulin and blood glucose in gastro-enterectomized dogs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 234(1). 118–38. 1 indexed citations

14.

Heptner, W., H. Neubauer, & R Schleyerbach. (1974). Glucose tolerance and insulin secretion in rabbits and dogs after ligation of the pancreatic ducts. Diabetologia. 10(3). 193–196. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact